IMI- Innovative Medicines Initiative

IMI- Innovative Medicines Initiative Joint Undertaking is a unique pan-European public private partnership aiming to foster collaboration between all relevant stakeholders including large and small biopharmaceutical and healthcare companies, regulators, academia and patients.

Call Topics:
Imaging biomarkers for anticancer drug development.
New tools for target validation to improve drug efficacy (oncology).
Molecular biomarkers: accelerating cancer therapy development and refining patient care.
Identification and development of rapid point of care diagnostic tests for bacterial diagnosis to facilitate conduct of clinical trials and clinical practice.
Understanding aberrant adaptive immunity mechanisms.
Translational research in chronic immune-mediated disease: bridging between animal models and humans.
Drug/disease modelling: library & framework.
Open pharmacological space.
Electronic Health Records (EHR)

Further Information:
http://imi.europa.eu/calls-02-stage1_en.html

Contact Person:
David Shem-Tov - david.s@tx.technion.ac.il
Jacky Lavan - jackl@dp.technion.ac.il